• The need for Thrombectomy-capable Stroke Centers (TSC) certification remains high as the study finds 64 percent of areas are classified as very high/high need areas due to a maximum drive time of 30 minutes.

HONOLULU, February 6, 2019 — The need for Thrombectomy-capable Stroke Centers (TSC) certification remains high as 64 percent of communities are beyond the maximum drive time of 30 minutes, according to a study presented today presented in Honolulu at the American Stroke Association’s International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

The study, “A Proposed Methodology Success to Determine the Need for Certified Thrombectomy Capable Stroke Centers,” assesses travel time between Comprehensive Stroke Centers and Thrombectomy-capable Stroke Centers to measure the time period that endovascular therapy is administered.  This study’s results, which show that 32 percent of the country is classified as a “very high need” area and an additional 32 percent classified as a “high need” area from TSCs with a 30-minute maximum drive time, will aid regional authorities in determining if a TSC should be included in a transport destination routing plan in their stroke systems of care.

“While the severe stroke patients benefiting from a thrombectomy only make up 15-20 percent of all strokes at most, the evidence shows that timely access to this procedure is beneficial to this set of patients,” said Lee H. Schwamm, MD, FAHA, FANA

Executive Vice Chairman, Neurology Department at Massachusetts General Hospital and longtime American Heart Association/American Stroke Association volunteer expert. “The end goal is for every step of the patient care continuum – from stroke center, hospital emergency room and emergency medical service - to follow the evidence-based guidelines set forth for quick evaluation and treatment of strokes of all magnitudes.” 

Poster Board Number LBP21 / Presentation Number LBP21 - A Proposed Methodology to Determine the Need for Certified Thrombectomy Capable Stroke Centers

Authors: Lee H. Schwamm, MD, FAHA, FANA, MGH, Boston, MA; Brette Tschurtz, Amy Slott, Scott Williams, Joint Commission, Oakbrook Terrace, IL; Ed Jauch, MUSC, Ashville, NC; David Baker, Joint Commission, Oakbrook Terrace, IL

Note: Scientific presentations take place at 6:30 PM HST/11:30 PM- EST Wednesday, Feb. 6, 2019.

Author disclosures are noted on the abstracts.

Additional Resources:

  • For more news at AHA International Stroke Conference 2019, follow us on Twitter @HeartNews  #ISC19.

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at https://www.heart.org/en/about-us/aha-financial-information.


About the American Stroke Association

The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.

For Media Inquiries and ASA Expert Perspective: 214-706-1173

Karen Springs: 214-706-4831; karen.springs@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

Feb. 6-8, 2019: AHA News Media Office at the Honolulu Convention Center: 808-792-6530

heart.org and strokeassociation.org